Novartis | NOVN - Market Capitalization


Novartis reported $239.03B in Market Capitalization this October of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 444.6B 59.91B Jun/2026
Alcon AG USD 33.76B 3.29B Jun/2026
Almirall EUR 2.76B 472.53M Dec/2025
Amgen USD 195.44B 5.55B Jun/2026
AstraZeneca USD 289.99B 11.26B Jun/2026
Bayer EUR 47.56B 8.87B Jun/2026
Biogen USD 31.9B 5B Jun/2026
Bristol-Myers Squibb USD 117.66B 6.17B Jun/2026
Eli Lilly USD 1.13T 260.54B Jun/2026
Fresenius EUR 22.51B 2.45B Jun/2026
Fresenius Medical Care EUR 10.55B 766.96M Jun/2026
Genmab DKK 17.1B 88.06B Jun/2026
Gilead Sciences USD 156.86B 16.13B Jun/2026
GlaxoSmithKline GBP 80.14B 3.66B Jun/2026
GRIFOLS EUR 5.41B 181.49M Jun/2026
Hikma Pharmaceutical USD 4.63B 1.42B Dec/2025
J&J USD 611.36B 32.21B Jun/2026
Lakefront Biotherapeutics EUR 1.73B 2.64M Jun/2026
Lonza CHF 39.68B 980.61M Jun/2025
Merck EUR 18.98B 27.8B Jun/2026
Merck USD 317.37B 20.27B Jun/2026
Novartis USD 240.59B 67.17B Jun/2026
Novartis USD 288.26B 25.18B Mar/2026
Novo Nordisk A/S DKK 1.4T 373.76B Jun/2026
Orion EUR 10.15B 316M Jun/2026
Pfizer USD 138.44B 15.37B Jun/2026
Philips EUR 23.09B 615.44M Jun/2026
Recordati EUR 10.44B 184.5M Jun/2026
Regeneron Pharmaceuticals USD 65.37B 16.31B Jun/2026
Roche Holding CHF 270B 3.66B Jun/2026
Sanofi EUR 91.15B 9.12B Jun/2026
UCB EUR 46.41B 13.94B Dec/2025